Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

CTA approved in Vietnam for phase I/II/III study of SARS-CoV-2 vaccine ARCT-154

Aug. 3, 2021

Intranasal vaccination with ChAdOx1 nCoV-19 reduces viral shedding in preclinical models

Aug. 3, 2021

Vaxart's IND application for S-only oral tablet COVID-19 vaccine cleared in U.S.

Aug. 3, 2021

Evolutionary modeling warns of COVID-19 vaccine resistance

Aug. 2, 2021

Deuterated GC-376 variants show efficacy in model of SARS-CoV-2 infection

Aug. 2, 2021

Enyo reports promising phase II data for vonafexor in patients with chronic hepatitis B

Aug. 2, 2021

SymBio opens phase IIa study of brincidofovir in subjects with adenovirus infection

July 30, 2021

S2X259, novel human MAb with potential to overcome the emergence of SARS-CoV-2 variants

July 30, 2021

AUG-3387 binds and neutralizes the SARS-CoV-2 Delta variant in vitro

July 30, 2021

Vaxart's oral norovirus vaccine boosts immune responses in previously vaccinated subjects

July 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...